This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Curative instruction sought by Insulet in US trade secret trial with EOFlow

By Melissa Ritti ( November 12, 2024, 17:10 GMT | Insight) -- A jury will reconvene today in Massachusetts as trial continues over allegations EOFlow misappropriated Insulet trade secrets directed to the design of the “Omnipod” insulin patch pump. Whether jurors will be instructed that companies are under no statutory obligation to catalog their inventory of trade secrets remains to be seen, but a note sent to a US judge last week suggests — at the very least — there is confusion on the issue.In a memorandum filed yesterday Insulet urged a US judge to issue a curative instruction to jurors that the Defend Trade Secrets Act has no requirement that trade secrets must be labeled and logged as such, internally, in order to remain protectable....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections